Neurology · 2016 · 390 citations · 15 references
AgricultureNutritionPharmacotherapyClinical NutritionGastroenterologyHuman NutritionConstipation ManagementFunctional Gastrointestinal DisordersIrritable Bowel SyndromePrebioticsProbioticsProbiotics In FoodsPlacebo ComparatorsPlacebo-controlled Efficacy AssessmentPrebiotic Effects On Gut MicrobiotaPrebiotic EfficacyPrebiotic Fiber AssessmentPrebiotic InterventionPrimary Efficacy EndpointsStool Diary
The study aimed to assess whether probiotics and prebiotics improve constipation in Parkinson disease patients. In a 4‑week, double‑blind, randomized controlled trial of 120 PD patients with constipation, participants received fermented milk containing multiple probiotic strains and prebiotic fiber or placebo daily. Fermented milk significantly increased complete bowel movements, with a mean weekly increase of 1.1 CBMs versus 0.1 for placebo (p = 0.002), and higher proportions achieving ≥3 CBMs (58.8% vs 37.5%) and ≥1 CBM increase (53.8% vs 25%).
Our objective was to evaluate the efficacy of probiotics and prebiotics in patients with Parkinson disease (PD) and constipation.We conducted a tertiary setting, randomized, double-blind, placebo-controlled trial in patients with PD with Rome III-confirmed constipation based on 2-week stool diary data at baseline. Patients (n = 120) were randomly assigned (2:1) to either a fermented milk, containing multiple probiotic strains and prebiotic fiber, or placebo, once daily for 4 weeks. The primary efficacy endpoint was the increase in the number of complete bowel movements (CBMs) per week. The key secondary endpoints were 3 or more CBMs and an increase by one or more CBMs per week during weeks 3 and 4.For the primary endpoint, the consumption of a fermented milk containing probiotics and prebiotics resulted in a higher increase in the number of CBMs (mean 1.2, 95% confidence interval [CI] 0.8-1.6) than placebo (0.1, 95% CI -0.4% to 0.6%) (mean difference 1.1, 95% CI 0.4-1.8; p = 0.002). For the key secondary endpoints, a higher number of patients in the probiotics-prebiotics group vs the placebo group reported 3 or more CBMs (p = 0.030; 58.8% vs 37.5%; odds ratio = 2.4, 95% CI 1.1-5.2) and an increase by one or more CBMs (p = 0.004; 53.8% vs 25.0%; odds ratio = 3.5, 95% CI 1.8-8.1) during weeks 3 and 4.The consumption of a fermented milk containing multiple probiotic strains and prebiotic fiber was superior to placebo in improving constipation in patients with PD.NCT02459717.This study provides Class I evidence that for patients with PD who have constipation, fermented milk containing probiotics and prebiotics increases the frequency of CBMs.
15
Margaret M. Hoehn, Melvin D. Yahr · Neurology · 1967 · 12K citations · Full text
Recent Developments in Parkinson's Disease
Howard I. Hurtig · Neurology · 1987 · 1.9K citations
Medicine, Neurology, Neuroscience +12